All three lesions shared the t(X, 18; p11, q11) SS18-SSX1 gene fusion, canonically described in synovial sarcoma.25 Overall, there were no clear de novo genetic drivers of disease progression in either the metastasis or the recurrence (figure 1B, C). This evidence concerns the gene SS18 and synovial sarcoma.